Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | SVP, Research & Development | July 28, 2024 | July 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date July 28, 2024 · Filed July 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,357 |
Ending reported balance
After 2024-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-07-28 · Grant · Acquired 1,170 · Balance 36,951 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-07-28 · Tax withholding · Disposed 594 · Balance 36,357 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-28 · Exercise / conversion · Disposed 1,170 · Balance 0 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-27 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-05-27 · Grant · Acquired 4,376 · Balance 20,932 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2022-05-27 · Tax withholding · Disposed 2,170 · Balance 18,762 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Row 3 · 2022-05-27 · Disposition to issuer · Disposed 18,762 · Balance 0 F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Exercise / conversion · Disposed 4,376 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F5: Vested in full. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 3,925 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 3,925 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 2,743 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 823 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 4,268 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 4,268 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 1,962 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 2,625 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 3,510 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 10,642 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 2,303 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 3,924 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F4: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F5: Vested in full.
F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.
F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F9: 3,925 shares will vest on February 4, 2023.
F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F11: 4,268 shares will vest on February 4, 2023.
F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.
F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.
F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.
F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.
F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 4,662 | $166.36 | $775,583.84 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,575 F2 · price: The weighted average sale price for these transactions was $166.3629 per share, with a range of $164.33 to $167.61. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock OPtions · Derivative | 3,926 | $0.00 Strike: $59.12 | $0.00 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · derivative · entry 12 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924 Underlying: Common Stock · 3,926 shares Expires 2029-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 3,926 shares vested on the second anniversary date of the grant date, February 4, 2021; 1,962 shares will vest on the third anniversary date of the grant date, February 4, 2022; and 1,962 shares will vest on the fourth anniversary date of the grant date, February 4, 2023. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 2,970 | $0.00 Strike: $47.85 | $0.00 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · derivative · entry 11 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,970 shares Expires 2028-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 2,303 | $0.00 Strike: $46.41 | $0.00 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · derivative · entry 10 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,303 Underlying: Common Stock · 2,303 shares Expires 2028-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 4,606 shares vested on the second anniversary date of the grant date, January 16, 2020; 2,303 shares vested on the third anniversary date of the grant date, January 16, 2021; and 2,303 shares will vest on the fourth anniversary date of the grant date, January 16, 2022. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 3,585 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · derivative · entry 9 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,585 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 7,172 shares vested on the second anniversary date of the grant date, February 15, 2019; 3,588 shares vested on the third anniversary date of the grant date, February 15, 2020; and 3,585 shares vested on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 12,784 | $164.11 | $2,097,955.39 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,237 F1 · price: The weighted average sale price for these transactions was $164.1079 per share, with a range of $163.043 to $166.21. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 3,926 | $59.12 | $232,105.12 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 2,970 | $47.85 | $142,114.50 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 2,303 | $46.41 | $106,882.23 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 3,585 | $21.08 | $75,571.80 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,822 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,016 | $210.10 | $423,561.60 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 8 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,237 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 7 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,253 F5 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 02/04/2019. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,366 | $210.10 | $497,096.60 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,328 F4 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,694 F3 · shares: Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 01/16/2018. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · derivative · entry 10 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,055 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 3,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · derivative · entry 9 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,519 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.expiration_date: The shares of common stock issued pursuant to the release of these restricted stock units were released pursuant to deferral periods defined under the 2016 Employee Deferred Bonus Compensation Plan. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 542 | $217.79 | $118,042.18 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,088 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,055 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,630 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,725 | $217.79 | $375,687.75 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,575 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 19:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 3,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-012576 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:40 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 7,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011596 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 7,172 shares vested on the fourth anniversary date of the grant date, February 15, 2021. F5 · derivative.expiration_date: 7,172 shares vested on the fourth anniversary date of the grant date, February 15, 2021. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:40 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 3,683 | $227.97 | $839,613.51 |
DisclosureSEC source: 0001209191-21-011596 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,781 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 20:40 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 7,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-011596 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,464 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 67 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 18:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,192 | $228.68 | $501,266.56 |
DisclosureSEC source: 0001209191-21-008297 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,225 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2021 Filed Feb 5, 2021 18:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008297 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,417 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2021 Filed Feb 5, 2021 18:49 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008297 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,536 Underlying: Common Stock · 4,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: 4,268 shares vested on the first anniversary date of the grant date, February 4, 2021. F4 · derivative.expiration_date: 4,268 shares vested on the first anniversary date of the grant date, February 4, 2021. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 20:45 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 3,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-007596 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937 Underlying: Common Stock · 3,937 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant date. F2 · derivative.expiration_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 19:45 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 2,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006977 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,970 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: 2,970 shares vested on the third anniversary date of the grant date, January 29, 2021. F5 · derivative.expiration_date: 2,970 shares vested on the third anniversary date of the grant date, January 29, 2021. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 19:45 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,526 | $250.97 | $382,980.22 |
DisclosureSEC source: 0001209191-21-006977 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,149 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 29, 2021 Filed Feb 2, 2021 19:45 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 2,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-006977 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,675 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 106 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 20:28 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 2,072 | $287.48 | $595,650.27 |
DisclosureSEC source: 0001209191-20-045362 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,599 Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 18:25 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 2,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-041157 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,944 Underlying: Common Stock · 2,944 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: 982 shares will vest on the first anniversary date of the grant date, July 1, 2021; 981 shares will vest on the second anniversary date of the grant date, July 1, 2022; and 981 shares will vest on the third anniversary date of the grant date, July 1, 2023. F2 · derivative.expiration_date: 982 shares will vest on the first anniversary date of the grant date, July 1, 2021; 981 shares will vest on the second anniversary date of the grant date, July 1, 2022; and 981 shares will vest on the third anniversary date of the grant date, July 1, 2023. Read SEC document |
| May 27, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · derivative · entry 12 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,752 Underlying: Common Stock · 4,376 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F10 · derivative.exercise_date: On 05/27/2014, the Reporting Person was granted 17,505 restricted stock units vesting as follows: 4,377 shares vested on 05/27/2019; 4,376 shares vested on 05/27/2020; 4,376 shares will vest on 05/27/2021; and 4,376 shares will vest on 05/27/2022. F10 · derivative.expiration_date: On 05/27/2014, the Reporting Person was granted 17,505 restricted stock units vesting as follows: 4,377 shares vested on 05/27/2019; 4,376 shares vested on 05/27/2020; 4,376 shares will vest on 05/27/2021; and 4,376 shares will vest on 05/27/2022. Read SEC document |
| May 27, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 7 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,671 F4 · shares: The disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon vesting of restricted stock units. Read SEC document |
| May 27, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Reflects release of restricted stock units that were previously reported on Form 4. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 4,606 | $0.00 Strike: $46.41 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · derivative · entry 11 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,606 Underlying: Common Stock · 4,606 shares Expires 2028-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: 4,606 shares vested on 01/16/2020; 2,303 shares will vest on 01/16/2021; and 2,303 shares will vest on 01/16/2022. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 10,758 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · derivative · entry 10 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,585 Underlying: Common Stock · 10,758 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 7,172 shares vested on 02/15/2019; 3,586 shares vested on 02/15/2020; and 3,585 shares will vest on 02/15/2021. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 35,192 | $0.00 Strike: $15.40 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · derivative · entry 9 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,192 shares Expires 2026-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 17,596 shares vested on 02/10/2018; 8,798 shares vested on 02/10/2019; and 8,798 shares vested on 02/10/2020. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 17,596 | $0.00 Strike: $23.41 | $0.00 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · derivative · entry 8 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,596 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 17,596 shares vested on 02/05/2017; 8,798 shares vested on 02/05/2018; and 8,798 shares vested on 02/05/2019. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 68,152 | $174.44 | $11,888,148.64 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,599 F2 · price: The weighted average sale price for these transactions was $174.4358 per share, with a range of $171.69 to $180.50. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 4,606 | $46.41 | $213,764.46 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 10,758 | $21.08 | $226,778.64 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,145 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 35,192 | $15.40 | $541,956.80 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2020 Filed May 27, 2020 19:54 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 17,596 | $23.41 | $411,922.36 |
DisclosureSEC source: 0001209191-20-032445 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,195 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount of securities beneficially owned following this transaction include an additional 272 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:07 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Premium) · Derivative | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009033 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210 Underlying: Common Stock · 210 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F6 · derivative.exercise_date: The restricted stock units vest on the first anniversary date of the grant date, February 10, 2021. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2019 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:07 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units (Converted) · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009033 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,050 Underlying: Common Stock · 1,050 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. F4 · derivative.exercise_date: The restricted stock units vest on the date of grant, February 10, 2020. F5 · derivative.expiration_date: The restricted stock units were received in lieu of a percentage of the reporting person's 2019 cash bonus pursuant to the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:07 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 669 | $77.52 | $51,860.88 |
DisclosureSEC source: 0001209191-20-009033 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,327 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2020 Filed Feb 12, 2020 20:07 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-009033 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,996 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 20:32 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Unit · Derivative | 12,804 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-007068 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,804 Underlying: Common Stock · 12,804 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F2 · derivative.exercise_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant date. F2 · derivative.expiration_date: One-third of the shares will vest annually over a three-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:35 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionNon-Qualified Stock Options · Derivative | 6,620 | $0.00 Strike: $22.85 | $0.00 |
DisclosureSEC source: 0001209191-19-059404 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,620 shares Expires 2024-05-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 13,242 shares vested on the second anniversary date of the grant date, May 27, 2016. 6,621 shares vested on the third anniversary date of the grant date, May 27, 2017. 6,620 shares vested on the fourth anniversary date of the grant date, May 27, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.